Albemarle Corp: UBS cuts target price to $137 from $150
ALB•UBS cut its target price for Albemarle Corp to $137 from $150.
Related News
Regentis signs exclusive deal with AMI to distribute GelrinC in Israel
RGNT•
Parabilis Medicines initiates coverage with buy rating; price target $39
PBLS•
Park Dental Partners completes acquisition of Village Family Dental DSO
PARK•
Gray Media names Richard Haddox general manager of WLIO and WOHL in Lima, Ohio
GTN•
Luda Technology signs one-year deal to supply 1,050,000 metric tons of coal
LUD•